Clinical Trials Logo

Clinical Trial Summary

Aim: The aim of this study was to report the 24-Month radiographical and histological outcome on these previously reported calcium hydroxide (CH) and mineral trioxide aggregate (MTA) pulpotomies using of five percent sodium hypochlorite (NaOCl) as an antibacterial agent to clean the chamber prior to application of the pulpotomy agent.

Materials and Methods: 128 primary molars were randomly divided into two main groups according to pulpotomy material (CH/MTA) and into two sub-groups according to selected the antibacterial agent (NaOCl/physiologic saline) used in the pulpotomy procedure. After these procedures, teeth were followed radiographically for 24 months. Thirty-four successfully treated teeth whose successors roots had completed formation of at least two-thirds of their lengths were extracted for histological evaluation. Fisher's-exact test, Pearson's-chi-square test and MannWhitneyU test with Bonferroni correction were used for statistical analysis.


Clinical Trial Description

The procedure and possible discomforts, risks, and benefits had been fully explained to the parents of the children, and informed consent forms were signed.

A total of 64 children (37 boys and 27 girls), between six to 10 years old (mean=8.2 years old) who had at least two mandibular primary molars with nearly equal carious involvement that required pulpotomy were included in the study. Following anesthesia and rubber dam isolation, the pulpotomy procedure was realized. After amputation of the coronal pulp tissue, pulpal hemorrhage was controlled using dry sterile cotton pellets under slight pressure for approximately 5 min. Four teeth were excluded from the study because of uncontrolled bleeding.

A total of 124 teeth were randomly distributed (by a coin toss) among groups representing different pulpotomy materials (CH or MTA) and cleansing agents (NaOCl or physiologic saline).

CH pulpotomy (n = 62 teeth): After hemorrhage control, two teeth in each child were randomly assigned by the toss of a coin to receive two cleansing agents, the experimental disinfecting agent 5% NaOCl (Wizard, Rehber Chemistry, Istanbul, Turkey) or the physiologic saline. CH control (n = 31 teeth): Pulp chamber was cleansed with physiologic saline prior the CH pulpotomy. CH NaOCl (n = 31 teeth): Pulp chamber was cleansed with 5% NaOCl for 30 s prior the CH pulpotomy. Then, canal orifices were sealed with CH (Kalsin, Aktu, Izmir, Turkey) paste (CH powder mixed with physiologic saline). After the canal orifice dressing, the chamber was based with reinforced ZOE (IRM; Dentsply Caulk, Milford, DE) and the tooth immediately restored with a stainless steel crown (SSC; 3M ESPE, Seefeld, Germany).

MTA pulpotomy (n = 62 teeth): As stated above, following the hemorrhage control, two cleansing agents were randomly applied to the cavity. MTA control (n= 31 teeth): Pulp chamber was cleansed with physiologic saline prior the MTA pulpotomy. MTA NaOCl (n = 31 teeth): Pulp chamber was cleansed with 5% NaOCl for 30 s prior the MTA pulpotomy. Then, canal orifices were sealed with MTA (ProRoot MTA; Dentsply, Tulsa, OK, USA) and a moistened cotton pellet was placed over the MTA paste to allow setting of the material. Reinforced ZOE was placed as a temporary restoration; the ZOE and the cotton pellets were removed after 24 h, and the teeth finally restored with SSCs.

The treatments received follow-up evaluations every six months, for 24 months, following the completion of the treatments. One examiner, who was blinded to treatment type, evaluated the teeth clinically and radiographically. At follow-up appointments, clinical success was confirmed by the absence of spontaneous pain, pathologic mobility, tenderness to percussion, swelling, fistula, or gingival inflammation. Radiographic success was considered when internal/external root resorption and periapical/furcal radiolucency was not observed. Calcific metamorphosis of the pulp was not considered a failure. The data were analyzed using Fisher's exact, McNemar, and Pearson's chi-square tests with Bonferroni correction.

Histological assessment Clinically and radiologically successful teeth -whose successors roots had completed formation of at least two thirds of their lengths- were extracted for histopathological evaluation. Following extraction, the teeth were immediately immersed in 10 % buffered formalin, embedded in paraffin, and serially sectioned through the root canals in a mesiodistal direction using a microtome to obtain sections of 5 μm in thickness. Sections were stained using hematoxylin eosin and examined under a light microscope. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04270318
Study type Interventional
Source Izmir Katip Celebi University
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date March 2017

See also
  Status Clinical Trial Phase
Withdrawn NCT01878851 - Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.
Completed NCT04909827 - 3D-printed Endocrowns Versus Prefabricated Zirconia Crowns in Pulpally-treated Primary Molars Phase 4
Completed NCT03200938 - Clinical Applicability of PBS® CIMMO Cement in Pulpotomies N/A
Recruiting NCT04863222 - Clinical and Radiographic Success of MTA vs Biodentine Phase 4
Active, not recruiting NCT05554952 - Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries N/A
Completed NCT03779698 - BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars Phase 4
Completed NCT03395496 - Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up Early Phase 1
Not yet recruiting NCT05747300 - Wellroot PT Versus MTA in Pulpotomy of Primary Molars N/A
Not yet recruiting NCT06288477 - Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol N/A
Not yet recruiting NCT06219824 - Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars Phase 3
Completed NCT03718676 - Pulpotomy With Various MTA Materials and Ferric Sulphate N/A
Recruiting NCT05279820 - Comparative Study of the Outcome of Partial and Full Pulpotomy in Irreversible Pulpits N/A
Active, not recruiting NCT02298504 - Vital Pulp Treatment in Primary Teeth Phase 4
Completed NCT04010929 - Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy N/A
Terminated NCT02783911 - Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies N/A
Withdrawn NCT02393326 - Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars N/A
Completed NCT05792748 - Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth N/A
Completed NCT05680285 - Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment N/A
Completed NCT05297344 - Clinical Study of the Direct Pulp Capping in Primary Teeth N/A
Completed NCT03782714 - Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies N/A